Delivery Order SPE2DB25D3201-SPE2DB25FNNLP

Award Date 10/25/24
Potential Completion Date 11/18/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,753.36, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price, and the ultimate completion date is September 24, 2024. The contract is not designated with a set-aside requirement,...
This federal contract award is for the delivery of the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML to the Defense Logistics Agency (DLA). The $1,188.34 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 14, 2024, with a completion date of September 5, 2024. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,188.34, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating it was an open competition. The award includes an Indefinite Delivery Contract (IDC)...
The federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The total ceiling value of the contract is $4,753.36. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 14, 2024, with a period of performance through December 6, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products to the Defense Logistics Agency (DLA). The $3,565.02 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 9, 2024, with a completion date of September 30, 2024. The contract has no set-aside designation. As a large supplier of pharmaceuticals and medical supplies to the U.S. federal government, Amerisourcebergen holds...
This federal contract award, valued at $3,565.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $22,129.38 and runs through April 9, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $4,753.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The award has an ultimate completion date of November 12, 2024 and a firm fixed price pricing type. This contract is not designated with a set-aside requirement, indicating open...
This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML to the Defense Logistics Agency (DLA). The contract, valued at $4,917.64, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of December 11, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,917.64 firm fixed-price delivery order is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNNLP
    Delivery Order

This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price contract, valued at $14,260.08, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 18, 2024 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 1/24/25, 9:16 AM